Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Join Dr. Luis Macias, a double board-certified plastic surgeon, to learn more about new innovations of SkinCeuticals. Dr. Macias will present the latest science from SkinCeuticals. Faculty Luis Macias,…
New JDD Consensus Offers Practical Guidance on Cosibelimab for Advanced cSCC Have you read this article from the JDD A recent expert consensus addresses cosibelimab, a newly FDA approved PD-L1…
Discover a smarter way to meet your continuing medical education requirements DermEdge is a free CME platform from Forefront Dermatology and MedscapeLive! designed for today’s busy dermatology professionals. This on-demand…
Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…
Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…
Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…